Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
GlobeNewswire, Inc.
Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP...
Assured Raises $19M Series A Led by Insight Partners to Automate Healthcare Provider Operations with AI Agents
GlobeNewswire, Inc.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- This funding accelerates Assured’s mission to replace manual healthcare provider operations with AI agents, so providers get onboarded faster and patients receive care sooner.
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
GlobeNewswire, Inc.
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...
123rd Medical Group and Kentucky Guard Airmen honored for national excellence
DVIDS - Georgia
The Kentucky Air National Guard’s 123rd Medical Group has been named Air National Guard Medical Unit of the Year, and two of its officers have been recognized for individual excellence in the 2025 Air National Guard Medical Service Awards.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
GlobeNewswire, Inc.
TEL AVIV, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced...
Sheba Medical Center Collaborates with OpenAI on Its First International Healthcare Deployment
EIN Presswire
A Major Step in the Hospital’s AI Transformation, Collaboration Will Provide Clinicians with OpenAI's Most Advanced Clinical Reasoning Platform RAMAT GAN, ISRAEL, July 28, 2026 /EINPresswire.com/ -- Sheba Medical Center announced today a...
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
GlobeNewswire, Inc.
Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder...
Dandy Partners with Yeshiva University's New College of Dental Medicine to Power the Future of Digital Dentistry Education
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today announced a partnership with Yeshiva University's new College of Dental Medicine, the first new dental school to open in New York City in over 100 years.
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
GlobeNewswire, Inc.
Dr. Oliver Sartor brings more than 35 years advancing the clinical development and commercialization of oncology and radiopharmaceuticals Professor Michael Hofman brings more than 20 years pioneering molecular imaging and precision...
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
GlobeNewswire, Inc.
MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today reports business...
REGN DEADLINE: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
GlobeNewswire, Inc.
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) that a securities class action has been filed on behalf of shareholders who purchased Regeneron securities...
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
GlobeNewswire, Inc.
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be...
SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
GlobeNewswire, Inc.
TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel...
President Trump Hosts Historic Cabinet Meeting at Camp David
The White House
President Donald J. Trump convened his Cabinet today for the first live, televised Cabinet meeting at Camp David in American history.
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.